ANIP — ANI Pharmaceuticals, Inc.
6 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about ANIP (2026-11-05)
- ANI Pharmaceuticals reported Q3 2026 earnings that beat estimates, with adjusted EPS of $2.70 and revenue of $290.8 million.
- ANI scheduled a conference call and webcast for November 5, 2026, to discuss Q3 results and the proposed acquisition details.
| Bluesky | 4 | community |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |